CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change · Other events
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- 8-K Event Agreement ended
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Executive or director change · Shareholder vote results
Page 8 of 17 · 340 filings